Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
|Live BSE Quotes||Feb 23, 2017 (Close)|
|Price (Rs)667.15||Open (Rs) 678.00||High (Rs) 680.55||Low (Rs) 663.40|
|% Change-1.58||Volume 149,454||Value (Rs) 100,631,491||52-Week H/L 895.00 / 582.00|
|Live NSE Quotes||Feb 23, 2017 (Close)|
|Price (Rs)666.25||Open (Rs) 678.00||High (Rs) 680.90||Low (Rs) 663.00|
|% Change-1.76||Volume 4,259,200||Value (Rs) 2,855,858,866||52-Week H/L 895.00 / 582.00|
|EPS (Rs)* 39.65||P/E Ratio (x) 16.82||Market Cap (Rs m) 390,395.50||P/BV (x) 5.53|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|Aurobindo Pharma Share Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Global stock markets ended the week on a mixed note. Stock markets in Germany and China were the biggest gainers, with gains of 1.7% and 1.6% respectively. Further, Indian stock markets were also up by 1.5%. However, the UK and Brazil share markets were marginally down by 0.6% and 0.5%, respectively.
Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.
Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.
Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.
Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.More Views on News
Apurva closed a trade with gains of 18.24% for his Swing Trader subscribers. But he's not happy about it. Find out why.
Why buybacks may not always be a tempting proposition.
The investors are writing down their investments in these firms.
Will the proposed buyback change the fortunes of TCS?
If you think investing in the stock markets can make you wealthy, you need to know this truth.More